Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "Alliance"

145 News Found

Time to move from ‘Volume’ to ‘Value’ leadership to capture global market, says Mandaviya
Policy | July 03, 2022

Time to move from ‘Volume’ to ‘Value’ leadership to capture global market, says Mandaviya

Govt committed to supporting pharma companies with industry-friendly policies


Agilent to improve analysis speeds of genomics bioinformatics
Digitisation | June 08, 2022

Agilent to improve analysis speeds of genomics bioinformatics

Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data


Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
News | June 04, 2022

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030


PAYBACK India announces a strategic partnership with Apollo Pharmacy
News | June 01, 2022

PAYBACK India announces a strategic partnership with Apollo Pharmacy

PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India


AbbVie showcases its leadership in Rheumatology research with new data across multiple inflammatory joint diseases
Biotech | May 24, 2022

AbbVie showcases its leadership in Rheumatology research with new data across multiple inflammatory joint diseases

The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually


Aster DM Healthcare partners with Skye Air Mobility for drone delivery
News | May 17, 2022

Aster DM Healthcare partners with Skye Air Mobility for drone delivery

Following the successful completion of the 7day BVLOS trials, Skye Air targets to undertake approximately 80 flights, each carrying blood samples and medicines for Aster Clinics


New two-year Deucravacitinib data show promising results for severe plaque psoriasis
Biotech | May 12, 2022

New two-year Deucravacitinib data show promising results for severe plaque psoriasis

Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease


Mediso acquires nuclear medicine supplier Bartec Technologies
Biotech | May 05, 2022

Mediso acquires nuclear medicine supplier Bartec Technologies

In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership


Geocann and Averix Bio to partner on API phytocannabinoid ingredients
News | April 18, 2022

Geocann and Averix Bio to partner on API phytocannabinoid ingredients

This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors


Venus Remedies gets CII's Responsible Export Organisation Certification
News | April 13, 2022

Venus Remedies gets CII's Responsible Export Organisation Certification

A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess